- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Solventum Corp (SOLV)
Solventum Corp stock price live, this page displays NYSE SOLV stock exchange data. View the SOLV premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Solventum Corp real time stock price chart below.
What Is the Solventum Corp Stock Price Today?
The Solventum Corp stock price today is 74.20.
What Is the Stock Symbol for Solventum Corp?
The stock symbol for Solventum Corp is "SOLV."
What Stock Exchange Does Solventum Corp Trade On?
Solventum Corp is listed and trades on the NYSE stock exchange.
Is Solventum Corp a Good Stock to Buy?
Determining whether Solventum Corp—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the SOLV quote. (ISIN: US83444M1018)
What Is the Solventum Corp Stock Price Today?
The Solventum Corp stock price today is 74.20.
What Is the Stock Symbol for Solventum Corp?
The stock symbol for Solventum Corp is "SOLV."
What Stock Exchange Does Solventum Corp Trade On?
Solventum Corp is listed and trades on the NYSE stock exchange.
Is Solventum Corp a Good Stock to Buy?
Determining whether Solventum Corp—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the SOLV quote. (ISIN: US83444M1018)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
73.00
77.89
52 wk Range
60.70
88.20
Unusual trading volume
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
73.0077.89
52 wk Range
60.7088.20
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
SOLV Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Price Target
89.92
Upside
+21.18%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
6 analysts have revised their earnings downwards for the upcoming period
- Solventum receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- Solventum receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Solventum receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Solventum Corp Company Profile
Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates in three segments: Medsurg, Dental Solutions, and Health Information Systems. The Medsurg segment offers solutions for negative pressure wound therapy, advanced wound dressings, advanced skin care, I.V. site management, sterilization assurance, temperature management, surgical supplies, medical tapes and wraps, stethoscopes, medical electrodes, and medical technologies for original equipment manufacturers. Its Dental Solutions segment provides a suite of dental and orthodontic products, including brackets, aligners, restorative cements, and bonding agents. The Health Information Systems provides software solutions and services for health care systems, such as computer-assisted, physician documentation, direct-to-bill and coding automation, classification methodologies, speech recognition, and data visualization platforms. The company sells its products and services through direct-to-consumer, distribution, key account management, inside sales, and e-commerce. Solventum Corporation was incorporated in 2023 and is based in Maplewood, Minnesota.
Solventum Corp Earnings Call Summary for Q4/2025
- Solventum Q4 EPS of $1.57 missed forecast of $1.75 by 10.29%; stock fell 1.66% aftermarket to $73.83 amid margin pressures from logistics costs.
- Revenue reached $2.0B with 3.5% organic growth; gross margin declined 230bps sequentially to 53.5%, operating margin compressed to 19.9%.
- Strong performance in Dental Solutions and MedSurg segments offset by challenges; Acera acquisition integration progressing as planned.
- FY2026 guidance projects 2-3% organic sales growth with operating margin expansion to 21-21.5%; Acera expected to boost advanced wound care growth.
- Supply chain disruptions and strategic divestitures weighed on results; management focused on optimizing logistics and leveraging acquisition synergies.
Last Updated: 02/27/2026, 06:56 AM
Read Full TranscriptCompare SOLV to Peers and Sector
Metrics to compare | SOLV | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipSOLVPeersSector | |
|---|---|---|---|---|
P/E Ratio | 8.3x | 39.9x | −0.6x | |
PEG Ratio | 0.04 | −1.78 | 0.00 | |
Price/Book | 2.5x | 5.0x | 2.6x | |
Price / LTM Sales | 1.5x | 3.6x | 3.3x | |
Upside (Analyst Target) | 23.3% | 9.7% | 44.9% | |
Fair Value Upside | Unlock | 18.6% | 5.6% | Unlock |
Analyst Ratings
7 Buy
6 Hold
1 Sell
Ratings:
14 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 89.92
(+21.18% Upside)
Earnings
Latest Release
Feb 26, 2026
EPS / Forecast
1.57 / 1.75
Revenue / Forecast
1.99B / --
People Also Watch
FAQ
What Is the Solventum (SOLV) Stock Price Today?
The Solventum stock price today is 74.20 USD.
What Stock Exchange Does Solventum Trade On?
Solventum is listed and trades on the New York Stock Exchange.
What Is the Stock Symbol for Solventum?
The stock symbol for Solventum is "SOLV."
What Is the Solventum Market Cap?
As of today, Solventum market cap is 12.87B USD.
What Is Solventum's Earnings Per Share (TTM)?
The Solventum EPS (TTM) is 8.88.
When Is the Next Solventum Earnings Date?
Solventum will release its next earnings report on May 07, 2026.
From a Technical Analysis Perspective, Is SOLV a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Solventum Stock Split?
Solventum has split 0 times.
How Many Employees Does Solventum Have?
Solventum has 22000 employees.
What is the current trading status of Solventum (SOLV)?
As of Mar 01, 2026, Solventum (SOLV) is trading at a price of 74.20 USD, with a previous close of 76.94 USD. The stock has fluctuated within a day range of 73.00 USD to 77.89 USD, while its 52-week range spans from 60.70 USD to 88.20 USD.
What Is Solventum (SOLV) Price Target According to Analysts?
The average 12-month price target for Solventum is 89.92 USD, with a high estimate of 105 USD and a low estimate of 71 USD. 7 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Buy. The stock has an +21.18% Upside potential.
What Is the SOLV Premarket Price?
SOLV's last pre-market stock price is 72.80 USD. The pre-market share volume is 199,740.00, and the stock has decreased by -4.14, or -5.38%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.